That's right, and FDA studies can be posted before approval is met. That's one reason I argue its not necessarily a 6-9 month timeline. I agree with your argument first sales will come in February, if manufacturing launches soon.
We may actually agree more than we disagree. Again, I'm not arguing for $1 per share. I see it more likely in the 20-30 cent range, with initial sales. From there it depends what happens in the equine market and beyond. I want to see studies for diagnosing infection.